Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cashflow Statement

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Profit Before Tax₹2,399 Cr₹1,671 Cr₹1,975 Cr₹1,692 Cr₹1,438 Cr
Adjustment ₹212 Cr₹298 Cr₹31 Cr₹-5.66 Cr₹105 Cr
Changes In working Capital ₹20 Cr₹167 Cr₹-586 Cr₹-95 Cr₹-140 Cr
Cash Flow after changes in Working Capital ₹2,632 Cr₹2,136 Cr₹1,419 Cr₹1,591 Cr₹1,403 Cr
Cash Flow from Operating Activities ₹2,152 Cr₹1,813 Cr₹920 Cr₹1,137 Cr₹1,072 Cr
Cash Flow from Investing Activities ₹-2,082 Cr₹-1,054 Cr₹-1,369 Cr₹-1,222 Cr₹-439 Cr
Cash Flow from Financing Activities ₹5.27 Cr₹-740 Cr₹605 Cr₹-7.81 Cr₹-527 Cr
Net Cash Inflow / Outflow ₹76 Cr₹19 Cr₹155 Cr₹-93 Cr₹106 Cr
Opening Cash & Cash Equivalents ₹305 Cr₹283 Cr₹127 Cr₹220 Cr₹116 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹1.17 Cr₹2.32 Cr₹0.48 Cr₹0.38 Cr₹3.60 Cr
Closing Cash & Cash Equivalent ₹382 Cr₹305 Cr₹283 Cr₹127 Cr₹226 Cr

Compare Cashflow Statement of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,303.1 Cr 1.1% -7% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-7%

9.7%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses